In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's ...

Author Capital Partners ("Author Capital" or "AuthorCap"), a Chicago-based principal investment firm, in partnership with ...

Chemotherapy saves lives, but for early-stage breast cancer, it may sometimes do more harm than good. An oncologist explains ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Low-dose CT scan helps detect lung cancer early, improving survival. Learn who needs LDCT screening, its benefits, risks and how it saves lives.

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...

Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers ...